ANKRD1 and kidney disorder: Interestingly, blocking of mTORC2 with PP242, an mTOR kinase inhibitor, halted the expression of YAP/TAZ and their target genes CTGF and ankyrin repeat domain 1 (ANKRD1) in cultured fibroblasts and UUO-induced nephropathy (Table 1).